Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.6 USD | -1.21% | -0.80% | +3.52% |
05:12pm | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
04:08pm | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.48% | 287B | |
+33.05% | 700B | |
-4.93% | 358B | |
+18.84% | 330B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.02% | 161B | |
-1.93% | 157B | |
+3.70% | 124B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Barclays Adjusts Price Target on AbbVie to $185 From $175, Maintains Overweight Rating